EPREmergency Preparedness & Response
- Specific Hazards
- Bioterrorism
- A–Z
- Anthrax
- Arenaviruses
- Botulism
- Brucella
- Cholera
- Ebola virus
- E. coli
- Food safety threats
- Glanders
- Lassa fever
- Marburg virus
- Melioidosis
- Plague
- Q fever
- Salmonella
- Shigella
- Smallpox
- Smallpox Basics
- Vaccine Basics
- Clinicians
- Vaccination Q & A (for professionals)
- Health Officials
- People Selected for Response Teams
- Diagnosis/
Evaluation - Lab Testing
- Infection Control
- Surveillance & Investigation
- Preparation & Planning
- Response
- Vaccination
- Images
- Medical Management
- Training & Education
- References
- Tularemia
- Typhoid fever
- Viral hemorrhagic fevers
- List by Category
- Fact Sheets
- Case Definitions
- Training
- Surveillance
- Preparation & Planning
- First Responders
- Lab Info
- A–Z
- Chemical
- A–Z
- Abrin
- Adamsite
- Ammonia
- Arsenic
- Arsine
- Barium
- Benzene
- Brevetoxin
- Bromine
- BZ
- Carbon monoxide
- Chlorine
- Chromium
- Colchicine
- Cyanide
- Digitalis
- Ethylene glycol
- Hydrazine
- Hydrofluoric acid
- Lewisite
- Melamine
- Mercury
- Methyl bromide
- Methyl isocyanate
- Nicotine
- Nitrogen mustard
- Opioids
- Organic solvents
- Osmium tetroxide
- Paraquat
- Phosgene
- Phosgene oxime
- Phosphine
- Phosphorus
- Pulmonary agents
- Ricin
- Sarin
- Saxitoxin
- Selenium
- Sodium azide
- Sodium monofluoroacetate
- Soman
- Strychnine
- Sulfur mustard
- Sulfuryl Fluoride
- Super Warfarin
- Tabun
- Tetrodotoxin
- Thallium
- Trichothecene
- Unidentified Chemical
- VX
- List by Category
- Chemical-Specific Fact Sheets
- Toxicology FAQs
- Case Definitions
- Toxic Syndrome Descriptions
- Toxicological Profiles
- Training
- First Responders
- Medical Management
- Emergency Response Cards
- Lab Info
- Surveillance
- Preparation & Planning
- A–Z
- Radiation
- Mass Casualties
- Natural Disasters & Severe Weather
- Recent Outbreaks & Incidents
- Bioterrorism
- Preparedness for All Hazards
- What CDC Is Doing
- What You Can Do
- What's New
Anthrax: Treatment
See Anthrax: Exposure Management/Prophylaxis for information about medication for persons who may have been exposed to anthrax but who currently show no symptoms of anthrax.
Overviews
- Q & A: Treatment
Side effects, antibiotics...
Sep 9, 2004 - Fact Sheet: Anthrax Information for Health Care Providers
Includes causes, systems affected, transmission...
Mar 8, 2002 (last reviewed Feb 22, 2006)
Specific Drugs
-
Patient Information: Ciprofloxacin
General information for patients prescribed ciprofloxacin for anthrax. Includes side effects & precautions.
Jan 20, 2004 -
Patient Information: Doxycycline
General information for patients prescribed doxycycline for anthrax. Includes side effects & precautions.
Jan 20, 2004 - Patient Information: Amoxicillin
General information for patients prescribed amoxicillin for anthrax. Includes side effects & precautions.
Guidelines
- MMWR: Interim Recommendations for Antimicrobial Prophylaxis for Children & Breastfeeding Mothers & Treatment of Children with Anthrax
MMWR 2001 Nov 16;50(45):1014-1016.
PDF (262 KB/24 pages) - MMWR: Investigation of Bioterrorism-Related Anthrax & Interim Guidelines for Exposure Management & Antimicrobial Therapy, October 2001
MMWR 2001 Oct 26;50(42):909-919.
PDF (213 KB/32 pages) - Community-Based Mass Prophylaxis: A Planning Guide for Public Health Preparedness
Planning guide to help state, county, & local officials meet federal requirements to prepare for public health emergencies. Outlines five components of mass prophylaxis response to epidemic outbreaks. Addresses dispensing operations using a comprehensive operational structure for Dispensing/Vaccination Centers (DVCs) based on the National Incident Management System (NIMS). (Developed by Weill Medical College of Cornell University for the Agency of Healthcare Research & Quality [AHRQ].)
Sep 2004
Historical Archives: 2001 Outbreak & Other Incidents
-
EID Journal: Clinical Issues in the Prophylaxis, Diagnosis, & Treatment of Anthrax
Emerging Infectious Diseases 2002 Feb;8(2):222-225. -
EID Journal: Demand for Prophylaxis after Bioterrorism-related Anthrax Cases, 2001
Emerging Infectious Diseases 2005 January;11(1). -
Statement by the Department of Health & Human Services Regarding Additional Options for Preventive Treatment For Those Exposed to Inhalation Anthrax
Dec 18, 2001 -
Video Webcast & Presentations: Update on Options for Preventive Treatment for Persons at Risk for Inhalational Anthrax
Presentations & text transcript from 12/21/01 event. Webcast, provided by University of North Carolina School of Public Health
Dec 21, 2001 -
Video Webcast: Treatment Options for Postal & Other Workers Exposed to Anthrax
For postal & other workers. Reviews options for people exposed to airborne anthrax spores, who may be at risk for inhalation anthrax. Archived webcast provided by University of North Carolina School of Public Health, plus online presentation.
Dec 21, 2001
- Share
- Add this to...
- Favorites
- Del.icio.us
- Digg
- Google Bookmarks
- Technorati
- Yahoo MyWeb
- Updates
- Subscribe
- Listen
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov